Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study

The Burden of Clostridium Difficile Infection in Thai Population: the First Report in Southeast Asia by 2010 Nationwide Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02327520

Enrollment

204666

Registered

2014-12-30

Start date

2010-01-31

Completion date

2014-12-31

Last updated

2014-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium Difficile Infection

Keywords

Clostridium difficile infection, burden, nationwide study, South East Asia, Thailand, Epidemiology, Outcome Assessment (Health Care) [N04.761.559.590]

Brief summary

The authors retrieved in-patient medical data, including the expense, from the 2010 Thailand Nationwide Hospital Admission Database, which is part of the National Health Security Office (NHSO). The diagnosis of digestive diseases with any form of colitis listed in the causes, either as principal diagnosis or co-morbidity, coding by the ICD-10 was recorded. The inclusion criteria were: 1) diagnosis of enterocolitis due to Clostridium difficile (ICD10-A07); and 2) age of more than 18 years. If the data was incomplete, the case was excluded. The baseline characteristics, including age, sex, co-morbidity disease and history of endoscopy or surgery, were recorded. The burden of CDI was evaluated by length of hospital stay (LOS), mortality rate, and hospital charge.

Interventions

OTHERColitis with CDI treatment

All patients will be treated with standard treatment

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* The patients with the diagnosis of Clostridium difficile (ICD10-A07) * Age of more than 18 years.

Exclusion criteria

* Data incompleted

Design outcomes

Primary

Measure	Time frame	Description
Death rate and length of hospital stay in CDI during admission	participants will be followed for the duration of hospital stay, an expected average of 2 weeks	Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI.
Hospital charge of CDI	participants will be followed for the duration of hospital stay, an expected average of 2 weeks	Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026